Ross procedure in an infant weighing 4.5 kg: eight years follow-up

Mariko Kobayashi1, Yukihiro Takahashi, Makoto Ando

  • 1Department of Cardiovascular Surgery, Sakakibara Heart Institute, 3-16-1 Asahi-cho, Fuchu, Tokyo 183-0003, Japan.

The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai Zasshi
|January 18, 2006
PubMed

Insights

The Ross procedure successfully treated congenital aortic stenosis in an infant. The pulmonary autograft remained functional at age 8, despite requiring re-right ventricular outflow tract reconstruction.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Congenital aortic stenosis presents a significant challenge in pediatric cardiac surgery.
  • The Ross procedure, utilizing a pulmonary autograft, is a complex surgical option for aortic valve replacement.
  • Right ventricular outflow tract (RVOT) reconstruction is often necessary in conjunction with aortic valve procedures.

Observation:

  • A 6-month-old infant with congenital aortic stenosis underwent aortic valve replacement with a pulmonary autograft (Ross procedure).
  • Initial RVOT reconstruction involved a polytetrafluoroethylene (PTFE)-valved equine pericardial conduit.
  • At age 5, severe pulmonary stenosis necessitated re-RVOT reconstruction with a PTFE monocusp patch after failed percutaneous transluminal pulmonary valvotomy.

Findings:

  • The pulmonary autograft demonstrated no functional deterioration at age 8.
  • Aortic regurgitation was trivial at the 8-year follow-up.
  • The patient experienced significant somatic growth without compromising the autograft function.

Implications:

  • The Ross procedure can offer long-term functional benefits for aortic valve replacement in infants.
  • Successful re-RVOT reconstruction is crucial for managing complications like pulmonary stenosis post-Ross procedure.
  • This case highlights the durability of pulmonary autografts and the potential for managing complex pediatric congenital heart disease over time.

Related Concept Videos